What Did This CEO Just Do with Personal Shares of Karyopharm Therapeutics (NASDAQ: KPTI)?

Yesterday, the CEO of Karyopharm Therapeutics (KPTI – Research Report), Michael Kauffman, sold shares of KPTI for $290.6K. In addition to Michael Kauffman, 4 other KPTI executives reported Sell trades in the More »

The President & CSO of Karyopharm Therapeutics (NASDAQ: KPTI) is Selling Shares

Yesterday, the President & CSO of Karyopharm Therapeutics (KPTI – Research Report), Sharon Shacham, sold shares of KPTI for $290.6K. In addition to Sharon Shacham, 4 other KPTI executives reported Sell trades More »